Loading…
Sotera Health Company is projected to rise to $23.26 by 2027, a +26% move from its current price of $18.42. SHC is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $18.09 | $18.42 | $18.76 | +0.02% |
| Jul 14 | $17.96 | $18.43 | $18.91 | +0.03% |
| Jul 15 | $17.85 | $18.43 | $19.02 | +0.05% |
| Jul 16 | $17.77 | $18.43 | $19.12 | +0.06% |
| Jul 17 | $17.70 | $18.43 | $19.20 | +0.08% |
| Jul 18 | $17.63 | $18.44 | $19.28 | +0.10% |
| Jul 19 | $17.57 | $18.44 | $19.35 | +0.11% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $17.57 | $18.44 | $19.35 | +0.11% |
| Week 2 | $17.24 | $18.46 | $19.77 | +0.23% |
| Week 3 | $17.00 | $18.48 | $20.10 | +0.34% |
| Week 4 | $16.80 | $18.50 | $20.38 | +0.45% |
| Week 5 | $16.63 | $18.52 | $20.64 | +0.57% |
| Week 6 | $16.47 | $18.54 | $20.88 | +0.68% |
| Week 7 | $16.34 | $18.57 | $21.10 | +0.79% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs.
The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for medical devices, pharmaceutical, and food safety and advanced applications markets. The Nordion segment provides Cobalt-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. It also offers gamma irradiation systems.
The Nelson Labs segment provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020.
Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.
Sotera Health Company (SHC) is a healthcare stock with a current price of $18.39 and a market cap of $5.24B. It is ranked 1348 by market capitalization.
The stock trades with notable technical alignment, including SMA50 at $16.10 and SMA200 at $16.33, suggesting the price sits above key longer-term averages. The 30-day price range runs from $16.24 to $20.82, placing the current level near the upper end of that window.
The longer-term forecast shows a rising average price path with substantial upside in years beyond 2026, including 2030, 2040, and 2050, reflecting a bullish sentiment in the longer horizon.
A major floor 28.7% below — a decisive break under it would weaken the trend.
The nearest floor, 18.5% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 12.3% above — clearing it would confirm fresh momentum.
Key SHC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SHC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $18.03 | Buy | $18.09 | Buy |
| MA 10 | $17.85 | Buy | $17.76 | Buy |
| MA 20 | $17.00 | Buy | $17.22 | Buy |
| MA 50 | $16.16 | Buy | $16.48 | Buy |
| MA 100 | $15.66 | Buy | $16.17 | Buy |
| MA 200 | $16.34 | Buy | $15.84 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 70.01 | Sell |
| Stoch RSI (14) | 88.27 | Sell |
| CCI (20) | 110.17 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.12 | Buy |
| ROC (12) | 16.29 | Buy |
| Bollinger %B (20,2) | 0.88 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.46 | Buy |
| Awesome (5,34) | 1.56 | Buy |
| Ultimate (7,14,28) | 71.83 | Sell |
| Momentum (10) | 1.32 | Buy |
| Aroon Osc (25) | 100.00 | Buy |
| Hull MA (9) | 18.17 | Buy |
| ADX (14) | 26.36 | Buy |
| ATR (14) | 0.28 | Info |
The near-term technical picture is bullish, with sentiment rated as BULLISH and an RSI14 at 70. The price is above both the SMA50 ($16.10) and the SMA200 ($16.33), supporting a positive tempo near the current level. Key near-term support sits at $15.02, while resistance is at $18.39.
The 30-day range is $16.24 to $20.82, keeping the current price within that window. Annualized volatility is 40%, indicating higher-than-average fluctuation within the month.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $13.13 | $18.42 | $24.26 | 0% | Neutral | |
| $19.05 | $23.26 | $29.69 | +26% | Bullish | |
| $20.26 | $25.20 | $33.04 | +37% | Bullish | |
| $21.84 | $27.59 | $36.94 | +50% | Bullish | |
| $24.38 | $31.22 | $42.55 | +69% | Bullish | |
| $28.53 | $36.97 | $51.19 | +101% | Bullish | |
| $34.02 | $44.59 | $62.62 | +142% | Bullish | |
| $36.36 | $48.15 | $68.50 | +161% | Bullish | |
| $39.64 | $53.02 | $76.32 | +188% | Bullish | |
| $42.40 | $57.24 | $83.32 | +211% | Bullish | |
| $66.29 | $93.35 | $142.39 | +407% | Bullish | |
| $119.51 | $180.49 | $295.11 | +880% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $13.13 | $18.42 | $22.19 | +0.00% |
| August 2026 | $16.14 | $18.89 | $22.59 | +2.54% |
| September 2026 | $15.89 | $18.69 | $22.53 | -1.04% |
| October 2026 | $16.16 | $19.09 | $23.16 | +2.13% |
| November 2026 | $16.64 | $19.72 | $24.05 | +3.29% |
| December 2026 | $16.64 | $19.78 | $24.26 | +0.33% |
Click any year to see its month-by-month SHC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect SHC to range from $13.13 to $24.26 through 2026. The $18.42 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The SHC price prediction for 2027 points to an average of $23.26 (low $19.05, high $29.69) — a potential gain of +26% on today's $18.42. Momentum favours further upside here.
In 2028, SHC is projected to trade between $20.26 and $33.04, averaging $25.20 — a potential gain of +37% from today's $18.42. That is up +8% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Sotera Health Company's 2029 outlook centres on $27.59, within a $21.84 to $36.94 range. That is up +9% on the projected 2028 average. That marks a +50% change versus current levels. Momentum favours further upside here.
By 2030, SHC could reach as high as $42.55, with a base case around $31.22 and support toward $24.38 — roughly +69% from $18.42. Buyers look set to stay in control over this stretch.
Expect SHC to range from $28.53 to $51.19 through 2031. The $36.97 average target implies a +101% move from current prices. That is up +18% on the projected 2030 average. Momentum favours further upside here.
The SHC price prediction for 2032 points to an average of $44.59 (low $34.02, high $62.62) — a potential gain of +142% on today's $18.42. Buyers look set to stay in control over this stretch.
In 2033, SHC is projected to trade between $36.36 and $68.50, averaging $48.15 — a potential gain of +161% from today's $18.42. That is up +8% on the projected 2032 average. Momentum favours further upside here.
Sotera Health Company's 2034 outlook centres on $53.02, within a $39.64 to $76.32 range. That is up +10% on the projected 2033 average. That marks a +188% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, SHC could reach as high as $83.32, with a base case around $57.24 and support toward $42.40 — roughly +211% from $18.42. Momentum favours further upside here.
Expect SHC to range from $66.29 to $142.39 through 2040. The $93.35 average target implies a +407% move from current prices. That is up +63% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The SHC price prediction for 2050 points to an average of $180.49 (low $119.51, high $295.11) — a potential gain of +880% on today's $18.42. Momentum favours further upside here.
Investing $1,000 in SHC today (≈ 54.288817 SHC) could be worth
$9,798.43
+$8,798.43 (+880%) by 2050 · US Dollar
Based on the average projected SHC price of $180.49 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SHCwould be worth at today's price.
$1,000 invested in SHC on Jul 10, 2025 (≈ 84.104287 SHC) would be worth
$1,549.2
+$549.2 (+54.9%) today · 1.55× · US Dollar
Based on a SHC entry price of $11.89 vs. today's $18.42.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $17.93 | $1,027.33 | +2.7% |
| 1 month ago | $16.27 | $1,132.15 | +13.2% |
| 3 months ago | $15.36 | $1,199.22 | +19.9% |
| 6 months ago | $18.99 | $969.98 | -3.0% |
| 1 year ago | $11.89 | $1,549.2 | +54.9% |
| All time (5.0y) ago | $23.47 | $784.83 | -21.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SHC forecast.
Our base-case forecast reaches $37.00 around 2032.
Implied market cap at $37.00: $10.55B
The year-by-year forecast starts with 2026 showing a min of $13.13, an avg of $18.39, and a max of $24.18 with a 0% ROI and neutral sentiment.
From 2027 onward the outlook strengthens: 2027 avg $23.16 with ROI 25.9%; 2028 avg $25.00 with ROI 35.9%; 2029 avg $27.23 with ROI 48.1%; 2030 avg $30.83 with ROI 67.7%, all listed as bullish.
The momentum continues through 2031–2035, with 2031 avg $36.34 (ROI 97.6%), 2032 avg $43.66 (ROI 137.4%), 2033 avg $47.26 (ROI 157%), 2034 avg $51.89 (ROI 182.2%), and 2035 avg $55.81 (ROI 203.5%), all bullish.
Longer horizons show substantial upside: 2040 avg $90.61 (ROI 392.7%), 2050 avg $173.94 (ROI 845.8%), with max forecasts of $138.21 in 2040 and $284.41 in 2050.
Tap a question to reveal the answer.
In 2030, the forecast shows min $24.08, avg $30.83, max $42.03, ROI 67.7%, sentiment BULLISH.
Forecasts indicate bullish sentiment from 2027 onward with rising averages and positive ROI, e.g., 2027 avg $23.16 and ROI 25.9%, 2030 ROI 67.7%. These are estimates, not guaranteed.
Yes—the max forecast is $138.21 in 2040 and $284.41 in 2050, with 2040 avg $90.61 and 2050 avg $173.94.
Current price is $18.39; near-term support is $15.02 and resistance is $18.39.
The 30-day range is $16.24 to $20.82.
Sotera Health Company Community Discussion
0Share your Sotera Health Company price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.